BioDuro, a global contract research, development, and manufacturing organization (CRDMO), has opened a new laboratory in the Waigaoqiao district/Free-Trade Zone of Shanghai, China, for highly potent compound synthesis at the hundred-gram scale.

Operating within occupational exposure band 5 (OEB-5), this specialized facility is designed to accelerate discovery and early development programs for conjugated drugs, including antibody-drug conjugates (ADCs), peptide-drug conjugates (PDCs), and radionuclide-drug conjugates (RDCs).

The new OEB-5 lab is equipped to ensure the safe and efficient production of highly potent compounds and incorporates isolators, closed-system reactors, and a dedicated HEPA-filtered HVAC system. Its potent handling rating means that trained technicians can operate safely within an OEL of as little as 0.1 micrograms per cubic meter.

“The addition of this OEB-5 lab strengthens BioDuro’s capabilities in the development of highly potent drugs,” said Dr. Armin Spura, CEO of BioDuro. “As demand continues to grow for complex conjugated therapeutics, we remain committed to enhancing our capabilities and capacities, providing integrated solutions across chemistry, biology, and DMPK to accelerate the delivery of innovative treatments for global patients.”